Social Media Ideas for Argx

Argenx

Argenx Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System

Argan, Inc. (AGX) Q1 2027 Earnings Call Transcript

Argan: Solid Visibility And Disciplined Execution Still Justifies A Buy

Sales expansion

Sales expansion Anonymous (not verified) Tue, 07/07/2026 - 09:09 field_thread_url https://cafepharma.com/boards/threads/sales-expansion.695083/...

Argan (AGX) Q1 2027 Earnings Call Transcript

Image source: The Motley Fool. DATEThursday, June 4, 2026 at 5 p.m. ETCALL PARTICIPANTSChief Executive Officer — David WatsonChief Financial Officer — Joshua BaugherNeed a quote f...

Arcutis Biotherapeutics, Inc. (ARQT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Arcturus Therapeutics Holdings Inc. (ARCT) Shareholder/Analyst Call Prepared Remarks Transcript

Argan: Still Fueling America's AI

ARGT: Welcome To The 2nd Phase Of The Argentine Turnaround (Rating Upgrade)

Ardelyx: The Market Is Right To Discount This Revenue Growth

Argea Publishes Its 2025 Sustainability Report: Supply Chain, Decarbonisation and Ecodesign at the Heart of the Group’s...

Apogee Therapeutics: Targeting Atopic Dermatitis

Assicurazioni Generali S.p.A. (ARZGY) Q1 2026 Earnings Call Transcript

XRG Expands Gas Investments In The Americas

Adnoc’s XRG announced two major gas deals this week that deepen its presence in the Americas. It will acquire stakes in three blocks linked ...

Argo Graphene Solutions enters license and technology agreement with Grapherry

Argo Graphene Solutions has announced that it has entered into a license agreement with Grapherry in respect of Grapherry's proprietary STREAM graphene production platform and all...

Genmab

Genmab Anonymous (not verified) Thu, 07/02/2026 - 06:06 field_thread_url https://cafepharma.com/boards/threads/genmab.680642/ board name...

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedi...

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat

Agios Pharmaceuticals, Inc. (AGIO) Discusses Global License Agreement for Cevidoplenib and Strategic Expansion in Rare H...

What This $1.1 Million Insider Sale at Accelerant Means for Investors

Executed under a pre-arranged Rule 10b5-1 plan, the transaction reduces Radke's stake by just 0.28%, leaving him with ~28.6 million shares worth $379 million.

Genmab

Genmab Anonymous (not verified) Mon, 07/13/2026 - 12:14 field_thread_url https://cafepharma.com/boards/threads/genmab.680642/ board name...